| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/12/2008 | WO2008031770A3 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 09/12/2008 | WO2008027993A3 Drug delivery systems comprising solid solutions of weakly basic drugs |
| 09/12/2008 | WO2008020056A3 Aerosol formulation containing beta agonists and steroids |
| 09/12/2008 | WO2008018024A3 Porous coating incorporating fluid reservoirs |
| 09/12/2008 | WO2008008801A3 Solid oral dosage vitamin and mineral compositions |
| 09/12/2008 | WO2008002567A3 Methods of treating conditions by sustained release administration of benzimidazole derivatives |
| 09/12/2008 | WO2007146426A3 Nanoshells for drug delivery |
| 09/12/2008 | CA2680449A1 Pharmaceutical composition comprising candesartan cilexetil |
| 09/12/2008 | CA2680206A1 Nanoparticle delivery systems for membrane-integrating peptides |
| 09/12/2008 | CA2679892A1 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids |
| 09/12/2008 | CA2679782A1 Oral administration of a calcitonin |
| 09/12/2008 | CA2679539A1 Dehydrated granular composition and biomedical applications thereof |
| 09/12/2008 | CA2679409A1 Rapid-disintegration monolayer film for the oral administration of active substances |
| 09/12/2008 | CA2679370A1 Fast-dissolving/disintegrating film preparation having high proportion of active |
| 09/12/2008 | CA2679316A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 09/12/2008 | CA2678794A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/12/2008 | CA2678424A1 Percutaneous administration device of bisoprolol |
| 09/12/2008 | CA2678367A1 Sustained release compositions using wax-like materials |
| 09/12/2008 | CA2677076A1 Compositions comprising carisoprodol and methods of use thereof |
| 09/12/2008 | CA2677036A1 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same |
| 09/12/2008 | CA2670539A1 Anesthetic spray composition |
| 09/12/2008 | CA2648581A1 Compositions and methods for treating b- cell malignancies |
| 09/11/2008 | US20080221557 Method of opening reservoir of containment device |
| 09/11/2008 | US20080221556 Device For the Controlled Release of a Predefined Quantity of a Substance |
| 09/11/2008 | US20080221555 Method for wirelessly monitoring implanted medical device |
| 09/11/2008 | US20080221524 Flexible transdermal drug delivery device for uniform penetration of chemodenervating botulinum toxins |
| 09/11/2008 | US20080221500 Implant having MEMS Flow Module with Movable, Flow-Controlling Baffle |
| 09/11/2008 | US20080221156 Stable formulations of ace inhibitors, and methods for preparation thereof |
| 09/11/2008 | US20080221144 Controlled Release Formulations |
| 09/11/2008 | US20080221121 Controlled release of sterile freeze dried aripirazole in water for intramuscular injection |
| 09/11/2008 | US20080221065 Pharmaceutical formulations; epothilone and mannitol or a cyclodextrin parenteral administration in the form of an infusion concentrate or lyophilised composition |
| 09/11/2008 | US20080221062 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221020 Dendrimers as Molecular Translocators |
| 09/11/2008 | US20080220406 Physiologically acceptable aqueous solutions and methods for their use |
| 09/11/2008 | US20080220403 System and method for managing diabetes |
| 09/11/2008 | US20080220092 Overcoming active agent tolerance, which may be experienced from continuous administration, improve patient compliance, and in some cases reducing the amount of drug needed per dose due to advantages of biosynchronization |
| 09/11/2008 | US20080220081 Water-Dispersible Xanthan Gum Containing Composition |
| 09/11/2008 | US20080220080 multiparticulate pharmaceutical form, comprising pellets with a multilayer structure for controlled active ingredient release, comprising a) a core layer comprising a substance having a modulating effect, b) an inner controlling layer which influences the delivery of the substance as modulator |
| 09/11/2008 | US20080220079 Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent; oral dosage forms; drug such as antivirals, vitamins, NSAIDS, antibiotics, insect growth regulators; dosing flexibility e.g. for animals |
| 09/11/2008 | US20080220078 Pharmaceutical Formulations |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220076 agent compositions comprising active agent particles having an effective average particle size of less than 2000 nm, wherein the compositions comprise a particle sequestrant are disclosed. Compositions having effective average particle size of less than 2000 nm, with no surfactants or phosphatides |
| 09/11/2008 | US20080220075 Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods making and using such compositions. |
| 09/11/2008 | US20080220074 Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220071 Aqueous Suspensions of Poorly Water-Soluble and Water-Insoluble Active Ingredients and Drying Powder Produced Therefrom |
| 09/11/2008 | US20080220070 Controlled release system and manufacturing method thereof |
| 09/11/2008 | US20080220069 Long Acting Injectable Crystal Formulations of Estradiol Metabolites and Methods of Using Same |
| 09/11/2008 | US20080220068 Treatment and prevention of excessive scarring |
| 09/11/2008 | US20080220067 therein a broad spectrum antimicrobial agent for use in medical applications, such as an adhesive for surgical drapes, wound dressings and tapes, is provided. The adhesive is composed of acrylic polymers, tackifiers and a preferred antimicrobial agent, diiodomethyl-p- ditolylsulfone |
| 09/11/2008 | US20080220066 Anti-Viral Topical Gel Formulations Containing a Diuretic Such as Furosemide and/or a Cardiac Glycoside Such as Digoxin |
| 09/11/2008 | US20080220064 Extended release matrix formulations of morphine |
| 09/11/2008 | US20080220062 Sustained release of agents for localized pain management |
| 09/11/2008 | US20080220061 controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles zero-order release profiles, escalating release profiles or decreasing release profiles. The dosage forms of the present invention can include spatial variation of API dosage forms |
| 09/11/2008 | US20080220060 gastroretentive formulation comprising an active substance granulated with a mixture of a weak gelling agent, a strong gelling agent, and a gas generating agent and process for manufacturing said formulation. |
| 09/11/2008 | US20080220059 Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide |
| 09/11/2008 | US20080220058 Method and composition for improving hair growth |
| 09/11/2008 | US20080220057 Therapeutic compounds and methods of use |
| 09/11/2008 | US20080220056 Treatment for liver disease |
| 09/11/2008 | US20080220055 nanostructure particles having functional groups with binding affinity for platelets and endothelial walls, coupled to the surface of the particles, and encapsulating drugs, used for tissue-targeted therapy |
| 09/11/2008 | US20080220054 Modulation of drug release rate from electrospun fibers |
| 09/11/2008 | US20080220052 administering polylysine to mammals as dietetics |
| 09/11/2008 | US20080220051 Powdery Sterol Compositions Containing Colloid-Forming Agents |
| 09/11/2008 | US20080220037 nontoxic and biodegradable organophosphorus compounds, having a high receptivity for stainless steel, aluminum or dental surface and form self-assembling thin films on the surfaces; protective coatings |
| 09/11/2008 | US20080220033 Cosmetic ingredient and cosmetic composition containing the same |
| 09/11/2008 | US20080220032 Oral care layer and related method of manufacture |
| 09/11/2008 | US20080220030 Nanoparticles Comprising Chitosan and Cyclodextrin |
| 09/11/2008 | US20080220028 vaccines comprising an antigen and a self-adjuvanting carrier, useful for inducing antigen-specific mucosal and systemic immune responses in the host upon immunization |
| 09/11/2008 | US20080220027 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 09/11/2008 | US20080220026 a topical mixture comprising metal oxides or a hybrid of the metal oxide and a polymer, and an acceptable vehicle, used for improving the aesthetic and natural appearance of the skin; dermatology; cosmetics |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080219951 Fluid mixture for enhancing implantable drug delivery at body temperature |
| 09/11/2008 | DE102007011485A1 Darreichungsform mit erschwertem Missbrauch Dosage form with impeded abuse |
| 09/10/2008 | EP1967581A1 CMOS compatible microneedle structures |
| 09/10/2008 | EP1967234A1 Compressed chewing gum tablet |
| 09/10/2008 | EP1967211A1 Method of producing solid preparation disintegrating in the oral cavity |
| 09/10/2008 | EP1967194A1 Rectal use of a sodium chloride solution as an intestinal cleanser |
| 09/10/2008 | EP1967191A1 Controlled/modified release oral methylphenidate formulations |
| 09/10/2008 | EP1967188A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 09/10/2008 | EP1967186A1 Composition for soft contact lens and adsorption suppressing method |
| 09/10/2008 | EP1967185A1 Hydrogel-driven drug dosage form |
| 09/10/2008 | EP1967184A1 Controlled release solid preparation |
| 09/10/2008 | EP1967183A1 Controlled release solid preparation |
| 09/10/2008 | EP1967182A1 Pharmaceutical composition comprising a salt of rosigliatazone |
| 09/10/2008 | EP1967181A1 Pharmaceutical formulation comprising a CB1-Receptor compound in a solid solution and/or solid dispersion |
| 09/10/2008 | EP1967180A1 Topical composition comprising a retinoid receptor agonist |
| 09/10/2008 | EP1967171A1 Skin patch and method of producing the same |
| 09/10/2008 | EP1967170A1 Adhesive patch |
| 09/10/2008 | EP1966611A1 Method for dissolution testing of pharmaceutical products |
| 09/10/2008 | EP1966556A2 Method of making dried particles |
| 09/10/2008 | EP1965864A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 09/10/2008 | EP1965853A2 Device for controlled release of chemical molecules |
| 09/10/2008 | EP1965840A1 Absorbent article |
| 09/10/2008 | EP1965822A2 Ginger extract for inhibiting human drug transporters |
| 09/10/2008 | EP1965821A2 Ginger fraction for inhibiting human cyp enzymes |
| 09/10/2008 | EP1965816A2 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| 09/10/2008 | EP1965808A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof |
| 09/10/2008 | EP1965795A2 Metaxalone formulations and methods for the preparation thereof |